CN112806572A - 一种治疗冠心病的五谷杂粮粉 - Google Patents
一种治疗冠心病的五谷杂粮粉 Download PDFInfo
- Publication number
- CN112806572A CN112806572A CN202110067845.2A CN202110067845A CN112806572A CN 112806572 A CN112806572 A CN 112806572A CN 202110067845 A CN202110067845 A CN 202110067845A CN 112806572 A CN112806572 A CN 112806572A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- heart disease
- coronary heart
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 98
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 29
- 235000013339 cereals Nutrition 0.000 claims abstract description 39
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 26
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229940116229 borneol Drugs 0.000 claims abstract description 21
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 21
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 21
- 241000218176 Corydalis Species 0.000 claims abstract description 19
- 241000005787 Cistanche Species 0.000 claims abstract description 18
- 244000075850 Avena orientalis Species 0.000 claims abstract description 17
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 17
- 244000068988 Glycine max Species 0.000 claims abstract description 17
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 17
- 235000007215 black sesame Nutrition 0.000 claims abstract description 17
- 241001426056 Eleusine coracana subsp. coracana Species 0.000 claims abstract description 16
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 16
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 16
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 16
- 241000234435 Lilium Species 0.000 claims abstract description 16
- 235000007199 Panicum miliaceum Nutrition 0.000 claims abstract description 16
- 235000020234 walnut Nutrition 0.000 claims abstract description 16
- 241000304531 Allium macrostemon Species 0.000 claims abstract description 14
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 14
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 14
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 14
- 239000009136 dragon's blood Substances 0.000 claims abstract description 14
- 244000164480 Curcuma aromatica Species 0.000 claims abstract description 13
- 235000003398 Curcuma aromatica Nutrition 0.000 claims abstract description 13
- 235000006533 astragalus Nutrition 0.000 claims abstract description 13
- 108010010803 Gelatin Proteins 0.000 claims abstract description 12
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 12
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 12
- 229920000159 gelatin Polymers 0.000 claims abstract description 12
- 239000008273 gelatin Substances 0.000 claims abstract description 12
- 235000019322 gelatine Nutrition 0.000 claims abstract description 12
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 12
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 11
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 11
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 11
- 240000007049 Juglans regia Species 0.000 claims abstract 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000003814 drug Substances 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 15
- 238000002791 soaking Methods 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 235000007558 Avena sp Nutrition 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 241000237636 Pheretima Species 0.000 claims description 5
- 108010052008 colla corii asini Proteins 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000000703 high-speed centrifugation Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000005086 pumping Methods 0.000 claims description 5
- 239000009286 sanguis draxonis Substances 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- 239000001116 FEMA 4028 Substances 0.000 claims description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 4
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 4
- 229960004853 betadex Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 36
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 8
- 230000036541 health Effects 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 description 26
- 239000008280 blood Substances 0.000 description 26
- 230000006872 improvement Effects 0.000 description 26
- 208000002193 Pain Diseases 0.000 description 20
- 230000036407 pain Effects 0.000 description 20
- 210000003734 kidney Anatomy 0.000 description 19
- 210000002216 heart Anatomy 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 13
- 241000758789 Juglans Species 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000031225 myocardial ischemia Diseases 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 206010008479 Chest Pain Diseases 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000302 ischemic effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 241000243684 Lumbricus Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- 206010008092 Cerebral artery thrombosis Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000000859 sublimation Methods 0.000 description 2
- 230000008022 sublimation Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- HTBWBWWADZJXID-TXEJJXNPSA-N Wuweizisu C Chemical compound COC1=C2C=3C(OC)=C4OCOC4=CC=3C[C@H](C)[C@H](C)CC2=CC2=C1OCO2 HTBWBWWADZJXID-TXEJJXNPSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- JEJFTTRHGBKKEI-OKILXGFUSA-N deoxyschizandrin Chemical compound C1[C@H](C)[C@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-OKILXGFUSA-N 0.000 description 1
- JEJFTTRHGBKKEI-UHFFFAOYSA-N deoxyschizandrin Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- HTBWBWWADZJXID-UHFFFAOYSA-N gamma-schisandrin Natural products COC1=C2C=3C(OC)=C4OCOC4=CC=3CC(C)C(C)CC2=CC2=C1OCO2 HTBWBWWADZJXID-UHFFFAOYSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000001121 heart beat frequency Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003975 mesenteric artery Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/20—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof consisting of whole seeds or seed fragments
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Agronomy & Crop Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种治疗冠心病的五谷杂粮粉，涉及保健用品技术领域。该五谷杂粮粉，按照重量份数计，由以下组份组成：黑芝麻6～18份、赤小米5～11份、大豆4～14份、燕麦10～25份、薏米3～5份、百合8～11份、核桃7～17份、血竭3～7份、阿胶3～7份、延胡索2份～5份、郁金7～17份、柴胡4～8份、麦冬8～18份、黄芪3～8份、冰片10～20份、肉苁蓉6～13份、五味子3～9份、银花6～16份、三七5～8份、地龙1～3份、薤白4～9份。该五谷杂粮粉可有效治疗冠心病、缓解心绞痛且不会对患者带来副作用。
Description
技术领域
本发明涉及保健用品技术领域，且特别涉及一种治疗冠心病的五谷杂粮粉。
背景技术
冠心病指由于脂质代谢不正常，血液中的脂质沉着在原本光滑的动脉内膜上，在动脉内膜一些类似粥样的脂类物质堆积而成白色斑块，称为动脉粥样硬化病变，这些斑块渐渐增多造成动脉腔狭窄，使血流受阻，导致心脏缺血，产生心绞痛。
美国医学界提出了促血管新生治疗策略，即有无可能通过某些药物的治疗增加有功能的冠状动脉分支或侧支循环，达到恢复缺血心肌血供、改善病人症状和预后的目的。
但该治疗疾病的西药的治疗费用过高、毒副作用大的缺点，无法得到广泛应用；且现今市场上存在着许多的治疗心绞痛的中药药物，但是绝大多数都具有毒副作用，不良反应多，不宜长期使用。
发明内容
本发明的目的在于提供一种治疗冠心病的五谷杂粮粉，此五谷杂粮粉可有效治疗冠心病、缓解心绞痛且不会对患者带来副作用。
本发明解决其技术问题是采用以下技术方案来实现的。
一种治疗冠心病的五谷杂粮粉，按照重量份数计，由以下组份组成：黑芝麻6～18份、赤小米5～11份、大豆4～14份、燕麦10～25份、薏米3～5份、百合8～11份、核桃7～17份、血竭3～7份、阿胶3～7份、延胡索2份～5份、郁金7～17份、柴胡4～8份、麦冬8～18份、黄芪3～8份、冰片10～20份、肉苁蓉6～13份、五味子3～9份、银花6～16份、三七5～8份、地龙1～3份、薤白4～9份。
作为进一步改进，按照重量份数计，由以下组份组成：黑芝麻10～15份、赤小米7～9份、大豆6～8份、燕麦18～24份、薏米3～5份、百合8～10份、核桃11～15份、血竭3～5份、阿胶3～5份、延胡索2～4份、郁金10～14份、柴胡5～7份、麦冬13～16份、黄芪3～5份、冰片15份、肉苁蓉8～10份、五味子6～8份、银花12～16份、三七6～8份、地龙2份、薤白6～9份。
作为进一步改进，按照重量份数计，由以下组份组成：黑芝麻14份、赤小米8份、大豆7份、燕麦20份、薏米4份、百合9份、核桃12份、血竭4份、阿胶4份、延胡索3份、郁金11份、柴胡6份、麦冬15份、黄芪4份、冰片15份、肉苁蓉9份、五味子7份、银花14份、三七7份、地龙2份、薤白6份。
作为进一步改进，按照如下方法制备：
S11，将黑芝麻、赤小米、大豆、燕麦、薏米、百合和核桃分别进行炒制，然后研磨成粉后混合，得到第一粉料；
S12，将血竭、阿胶、延胡索、郁金、柴胡、麦冬、黄芪、冰片、肉苁蓉、五味子、银花、三七、地龙、薤白粉碎，大小控制在60-100目筛，得到第二粉料；
S13，将第二粉料混合均匀，置于通透袋内，用温度为20-40℃的凉开水浸泡6-8小时；
S14，加水煎煮三次，第一次持续0.6-1.2小时，第二、三次各0.8～1.4小时，第一次加水量为第二粉料总重量的3-4倍，第二、三次加水量为第二粉料总重量的5～8倍；
S15，将煎煮后的药液加入4倍量的乙醇，乙醇为95％以上的食用酒精，充分搅拌，静置冷藏12小时，滤液回收乙醇后抽进浓缩罐，经浓缩至原体积的1/2-1/3，得浓缩液；
S16，将浓缩液液倒入离心机中高速离心，弃去不溶物得到提取液；
S17，将提取液经真空减压泵浓缩到五分之一体积后，经真空干燥机进行干燥制得第三粉料；
S18，将所述第一粉料和所述第三粉料混合后，灭菌得到所述五谷杂粮粉。
作为进一步改进，步骤S12中，所述第二粉料的大小为80-85目筛。
作为进一步改进，步骤S13中，凉开水浸泡的温度为30℃。
作为进一步改进，步骤S13中，浸泡的时间为7小时。
作为进一步改进，步骤S14中，第一次煎煮的时间为0.8-1.0小时，第一次加水量为第二粉料总重量的3.5倍。
作为进一步改进，步骤S14中，第二、三次煎煮的时间为1～1.2小时，第二、三次加水量为第二粉料总重量的7倍。
作为进一步改进，步骤S12中的冰片在粉碎之前，先将其溶于乙醇中，并用β-环糊精包合。
本发明实施例治疗冠心病的五谷杂粮粉的有益效果是：本五谷杂粮粉以五谷杂粮为主方，以调和机体，温养肾脏，养胃护肝，以达到滋养肾脏的作用，同时避免中药摄入过多引起机体不适。中药成分中，主要起到滋补肾阴、温煦元阳、益气养血、活血化瘀、清解血毒、理气止痛的作用，具体的，本发明药物用甘温的血竭与微温的黄芪相配补益肾阴，补脾肺之气；肉苁蓉温壮肾阳，配伍辛温具有镇痛作用且治疗缺血性心脏病效果良好的延胡索，以温养下元，上药四味可奏阴阳并补之功；五味子酸温敛肺生津，全方可益气生津，敛阴止汗；冰片、郁金温通心阳，专治心阳虚之心悸；银花、五味子，可清热解毒、活血止痛；三七增加冠脉流量、改善心肌缺血、抗休克、肮心律失常、镇痛等；地龙对缺血性脑卒具有保护作用，并能改善缺血性脑组织中DA和5HT的代谢紊乱，并具有抗心律失常作用；薤白对实验性动脉粥样硬化有预防作用，并有扩冠治心绞痛作用，整体配伍合理，可有效实现治疗冠心病的作用且无副作用。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚，下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者，按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者，均为可以通过市售购买获得的常规产品。
下面对本发明实施例的治疗冠心病的五谷杂粮粉进行具体说明。
实施例1
一种治疗冠心病的五谷杂粮粉，按照重量份数计，由以下组份组成：黑芝麻6～18份、赤小米5～11份、大豆4～14份、燕麦10～25份、薏米3～5份、百合8～11份、核桃7～17份、血竭3～7份、阿胶3～7份、延胡索2份～5份、郁金7～17份、柴胡4～8份、麦冬8～18份、黄芪3～8份、冰片10～20份、肉苁蓉6～13份、五味子3～9份、银花6～16份、三七5～8份、地龙1～3份、薤白4～9份。
本发明各原料机理：
黑芝麻具有丰富的油脂和蛋白质，以及糖类、多种维生素和矿物质等，具有补肾、润肠等功效。
大豆富含多种氨基酸、不饱和脂肪酸等，维持人体肝脏、骨骼及皮肤的健康。
燕麦具有益肝和胃、护肤润燥、抗菌、抗氧化功效。
血竭，性味:甘、咸，平。归经:归心、肝经。功效:祛瘀定痛，止血生肌。主治:用于跌扑折损，内伤瘀痛；外伤出血不止。
阿胶，性味:甘，平。归经:归肺、肝、肾经。功效:补血滋阴，润燥，止血。主治:用于血虚萎黄，眩晕心悸，肌痿无力，心烦不眠，虚风内动，肺燥咳嗽，劳嗽咯血，吐血尿血，便血崩漏，妊娠胎漏。
延胡索，辛苦而温，入心、肝、脾经，具活血行气止痛之功，“治心痛欲死”(《雷公炮炙论》)，能行血中之气滞，气中之血滞，故为君药；三七甘苦而温，入肝、胃二经，可化瘀活血而定痛，能够祛瘀生新，化瘀不伤正；
郁金，味辛，入心、肝、胆经，辛能行能散，既能活血，又能行气，可活血止痛、行气解郁。丹参苦微寒，入心、肝经，活血祛瘀，通经止痛
黄芪，甘微温，入归肺、脾经。补气升阳，固表止汗，生津养血，行滞通痹。黄芪既可补气生血，使气旺血生，动力不竭，又能固护正气，防君、臣诸药行气化瘀克罚太过耗伤正气。
冰片，辛苦微寒，归心、脾、肺经，善走能散，具有散火、散气、散血、散滞、通窍、辟恶之功，“独行则势弱，佐使则有功”(《本草衍义》)，与诸药相伍，能开心窍，止痹痛，亦为佐药。诸药合用，共奏活血祛瘀，行气止痛之功，可使瘀血得去，脉道得通，则诸症自解。由于冰片极易升华，致贮存过程中含量容易下降，影响药物的疗效。因此，为避免冰片的升华，提高药物制剂的稳定性和疗效，在整体药材原料研磨前，先将其溶于乙醇中，并用β-环糊精包合，增加了对光、热、湿的稳定性，降低了其挥发性，以保持最终杂粮粉的疗效稳定性。
柴胡，味辛、苦，性微寒、归肝、胆、肺经，疏散退热，升阳舒肝。
麦冬，甘、微苦，微寒。润肺清心、泻热生津、化痰止呕、治嗽行水，养阴生津，润肺清心。
肉苁蓉，归经甘、咸，温。归肾、大肠经。补肾阳，益精血，润肠通便。《本草经疏》:滋肾补精血之要药，甘能除热补中，酸能入肝，咸能滋肾，肾肝为阴，阴气滋长，则五脏之劳热自退，阴茎中寒热痛自愈。
五味子，温；酸、甘；归肺、心、肾经。收敛固涩，益气生津，补肾宁心。五味子有扩血管作用。五味子素、五味子丙素、去氧五味子素等对于离体狗肠系膜动脉收缩均有抑制作用，能增加脉鼠离体心脏及麻醉狗冠脉血流量。五味子有利于组织细胞的氧气交换，能对心脏组织产生保护作用，还可平缓心跳频率和纾解高血压。
银花，甘、寒。归肺、胃经。功效：清热解毒。具有降血脂作用。能使机体外周血管灌流量增加，使动脉内皮细胞羟脯氨酸代谢缓慢，使内壁的胶原纤维含量相对减少，有利于防止血小板粘附，聚集及血栓形成，故有较好的抗动脉硬化作用。
三七增加冠脉流量、改善心肌缺血、抗休克、肮心律失常、镇痛等。
地龙，具有清热定惊、通络、平喘、利尿的功效。常炒制后用于高热、神昏、惊痫抽搐、关节痹痛、肺热喘咳、尿少水肿、高血压等症。
薤白、味辛、苦，性温，无毒，具有理气、宽胸、通阳、散结之功效，中医长期用于治疗治胸痹心痛。
该五谷杂粮饭按照如下方法制备：
所述粉剂的制备方法是：
一种治疗冠心病的五谷杂粮粉，按照重量份数计，由以下组份组成：黑芝麻6～18份、赤小米5～11份、大豆4～14份、燕麦10～25份、薏米3～5份、百合8～11份、核桃7～17份、血竭3～7份、阿胶3～7份、延胡索2份～5份、郁金7～17份、柴胡4～8份、麦冬8～18份、黄芪3～8份、冰片10～20份、肉苁蓉6～13份、五味子3～9份、银花6～16份、三七5～8份、地龙1～3份、薤白4～9份。
作为进一步改进，按照如下方法制备：
S11，将黑芝麻、赤小米、大豆、燕麦、薏米、百合和核桃分别进行炒制，然后研磨成粉后混合，得到第一粉料；
S12，将血竭、阿胶、延胡索、郁金、柴胡、麦冬、黄芪、冰片、肉苁蓉、五味子、银花、三七、地龙、薤白粉碎，大小控制在60-100目筛，得到第二粉料；
S13，将第二粉料混合均匀，置于通透袋内，用温度为20-40℃的凉开水浸泡6-8小时；
S14，加水煎煮三次，第一次持续0.6-1.2小时，第二、三次各0.8～1.4小时，第一次加水量为第二粉料总重量的3-4倍，第二、三次加水量为第二粉料总重量的5～8倍；
S15，将煎煮后的药液加入4倍量的乙醇，乙醇为95％以上的食用酒精，充分搅拌，静置冷藏12小时，滤液回收乙醇后抽进浓缩罐，经浓缩至原体积的1/2-1/3，得浓缩液；
S16，将浓缩液液倒入离心机中高速离心，弃去不溶物得到提取液；
S17，将提取液经真空减压泵浓缩到五分之一体积后，经真空干燥机进行干燥制得第三粉料；
S18，将所述第一粉料和所述第三粉料混合后，灭菌得到所述五谷杂粮粉。
作为进一步改进，步骤S12中，所述第二粉料的大小为80-85目筛。
作为进一步改进，步骤S13中，凉开水浸泡的温度为30℃。
作为进一步改进，步骤S13中，浸泡的时间为7小时。
作为进一步改进，步骤S14中，第一次煎煮的时间为0.8-1.0小时，第一次加水量为第二粉料总重量的3.5倍。
作为进一步改进，步骤S14中，第二、三次煎煮的时间为1～1.2小时，第二、三次加水量为第二粉料总重量的7倍。
作为进一步改进，步骤S12中的冰片在粉碎之前，为避免冰片的升华，提高药物制剂的稳定性和疗效，在整体药材原料研磨前，先将其溶于乙醇中，并用β-环糊精包合，增加了对光、热、湿的稳定性，降低了其挥发性，以保持最终杂粮粉的疗效稳定性。
实施例2
该五谷杂粮粉，按照重量份数计，由以下组份组成：
一种治疗冠心病的五谷杂粮粉，按照重量份数计，由以下组份组成：黑芝麻10～15份、赤小米7～9份、大豆6～8份、燕麦18～24份、薏米3～5份、百合8～10份、核桃11～15份、血竭3～5份、阿胶3～5份、延胡索2～4份、郁金10～14份、柴胡5～7份、麦冬13～16份、黄芪3～5份、冰片15份、肉苁蓉8～10份、五味子6～8份、银花12～16份、三七6～8份、地龙2份、薤白6～9份。
作为进一步改进，按照如下方法制备：
S11，将黑芝麻、赤小米、大豆、燕麦、薏米、百合和核桃分别进行炒制，然后研磨成粉后混合，得到第一粉料；
S12，将血竭、阿胶、延胡索、郁金、柴胡、麦冬、黄芪、冰片、肉苁蓉、五味子、银花、三七、地龙、薤白粉碎，大小控制在60-100目筛，得到第二粉料；
S13，将第二粉料混合均匀，置于通透袋内，用温度为20-40℃的凉开水浸泡6-8小时；
S14，加水煎煮三次，第一次持续0.6-1.2小时，第二、三次各0.8～1.4小时，第一次加水量为第二粉料总重量的3-4倍，第二、三次加水量为第二粉料总重量的5～8倍；
S15，将煎煮后的药液加入4倍量的乙醇，乙醇为95％以上的食用酒精，充分搅拌，静置冷藏12小时，滤液回收乙醇后抽进浓缩罐，经浓缩至原体积的1/2-1/3，得浓缩液；
S16，将浓缩液液倒入离心机中高速离心，弃去不溶物得到提取液；
S17，将提取液经真空减压泵浓缩到五分之一体积后，经真空干燥机进行干燥制得第三粉料；
S18，将所述第一粉料和所述第三粉料混合后，灭菌得到所述五谷杂粮粉。
作为进一步改进，步骤S12中，所述第二粉料的大小为80-85目筛。
作为进一步改进，步骤S13中，凉开水浸泡的温度为30℃。
作为进一步改进，步骤S13中，浸泡的时间为7小时。
作为进一步改进，步骤S14中，第一次煎煮的时间为0.8-1.0小时，第一次加水量为第二粉料总重量的3.5倍。
作为进一步改进，步骤S14中，第二、三次煎煮的时间为1～1.2小时，第二、三次加水量为第二粉料总重量的7倍。
实施例3
一种治疗冠心病的五谷杂粮粉，按照重量份数计，由以下组份组成：黑芝麻14份、赤小米8份、大豆7份、燕麦20份、薏米4份、百合9份、核桃12份、血竭4份、阿胶4份、延胡索3份、郁金11份、柴胡6份、麦冬15份、黄芪4份、冰片15份、肉苁蓉9份、五味子7份、银花14份、三七7份、地龙2份、薤白6份。
作为进一步改进，按照如下方法制备：
S11，将黑芝麻、赤小米、大豆、燕麦、薏米、百合和核桃分别进行炒制，然后研磨成粉后混合，得到第一粉料；
S12，将血竭、阿胶、延胡索、郁金、柴胡、麦冬、黄芪、冰片、肉苁蓉、五味子、银花、三七、地龙、薤白粉碎，大小控制在60-100目筛，得到第二粉料；
S13，将第二粉料混合均匀，置于通透袋内，用温度为20-40℃的凉开水浸泡6-8小时；
S14，加水煎煮三次，第一次持续0.6-1.2小时，第二、三次各0.8～1.4小时，第一次加水量为第二粉料总重量的3-4倍，第二、三次加水量为第二粉料总重量的5～8倍；
S15，将煎煮后的药液加入4倍量的乙醇，乙醇为95％以上的食用酒精，充分搅拌，静置冷藏12小时，滤液回收乙醇后抽进浓缩罐，经浓缩至原体积的1/2-1/3，得浓缩液；
S16，将浓缩液液倒入离心机中高速离心，弃去不溶物得到提取液；
S17，将提取液经真空减压泵浓缩到五分之一体积后，经真空干燥机进行干燥制得第三粉料；
S18，将所述第一粉料和所述第三粉料混合后，灭菌得到所述五谷杂粮粉。
作为进一步改进，步骤S12中，所述第二粉料的大小为80-85目筛。
作为进一步改进，步骤S13中，凉开水浸泡的温度为30℃。
作为进一步改进，步骤S13中，浸泡的时间为7小时。
作为进一步改进，步骤S14中，第一次煎煮的时间为0.8-1.0小时，第一次加水量为第二粉料总重量的3.5倍。
作为进一步改进，步骤S14中，第二、三次煎煮的时间为1～1.2小时，第二、三次加水量为第二粉料总重量的7倍。
本发明实施例治疗冠心病的五谷杂粮粉的有益效果是：本五谷杂粮粉以五谷杂粮为主方，以调和机体，温养肾脏，养胃护肝，以达到滋养肾脏的作用，同时避免中药摄入过多引起机体不适。中药成分中，主要起到滋补肾阴、温煦元阳、益气养血、活血化瘀、清解血毒、理气止痛的作用，具体的，本发明药物用甘温的血竭与微温的黄芪相配补益肾阴，补脾肺之气；肉苁蓉温壮肾阳，配伍辛温具有镇痛作用且治疗缺血性心脏病效果良好的延胡索，以温养下元，上药四味可奏阴阳并补之功；五味子酸温敛肺生津，全方可益气生津，敛阴止汗；冰片、郁金温通心阳，专治心阳虚之心悸；银花、五味子，可清热解毒、活血止痛；三七增加冠脉流量、改善心肌缺血、抗休克、肮心律失常、镇痛等；地龙对缺血性脑卒具有保护作用，并能改善缺血性脑组织中DA和5HT的代谢紊乱，并具有抗心律失常作用；薤白对实验性动脉粥样硬化有预防作用，并有扩冠治心绞痛作用，整体配伍合理，可有效实现治疗冠心病的作用且无副作用。
病例1
李某，男，57岁。近来总感觉胸前区疼痛，胸闷向肩部放射，持续15-20分钟，常年服用速效救心丸而缓解。体态偏胖，身高160公分，体重达90公斤，既往有高血压病史，服用多种药品，均无明显效果，服用本发明实施例1杂粮粉一个疗程，症状明显缓解，两疗程后，心绞痛停止发作。随访2年一直稳定，至今未复发。
病例2
王某，男，59岁，患者有心绞痛，有时候突然发作，但很快就会症状消失，发作时，疼痛难忍。一般在早晨吃完早餐，尤其在寒冷的冬天，激动时，易发作，经诊断，心电图不正常，ST短波下，T波倒置，右束之传导阻滞，中医认为是气虚、痰饮、血瘀症，使用本发明杂粮粉后一个月，胸痛好转，但仍气短，精神不佳，症状没有完全消除，继续服用本发明中药配方，一个月后，其他症状都以消除，复查心电图发现，ST波和T波都已正常。随访一年，一切情况良好。
病例3
陈某，女，46岁，患者2年前无明显诱因出现心前区疼痛，胸闷、气短，每次发作可持续10-20分钟，心电图显示心肌缺血。服用本发明实施例3药物二个疗程后，胸闷、气短症状缓解，心电图检查基本正常。随访2年一直稳定，至今未复发。
以上所描述的实施例是本发明一部分实施例，而不是全部的实施例。本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围，而是仅仅表示本发明的选定实施例。基于本发明中的实施例，本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
Claims (10)
1.一种治疗冠心病的五谷杂粮粉，其特征在于，按照重量份数计，由以下组份组成：黑芝麻6～18份、赤小米5～11份、大豆4～14份、燕麦10～25份、薏米3～5份、百合8～11份、核桃7～17份、血竭3～7份、阿胶3～7份、延胡索2份～5份、郁金7～17份、柴胡4～8份、麦冬8～18份、黄芪3～8份、冰片10～20份、肉苁蓉6～13份、五味子3～9份、银花6～16份、三七5～8份、地龙1～3份、薤白4～9份。
2.根据权利要求1所述的治疗冠心病的五谷杂粮粉，其特征在于，按照重量份数计，由以下组份组成：黑芝麻10～15份、赤小米7～9份、大豆6～8份、燕麦18～24份、薏米3～5份、百合8～10份、核桃11～15份、血竭3～5份、阿胶3～5份、延胡索2～4份、郁金10～14份、柴胡5～7份、麦冬13～16份、黄芪3～5份、冰片15份、肉苁蓉8～10份、五味子6～8份、银花12～16份、三七6～8份、地龙2份、薤白6～9份。
3.根据权利要求2所述的治疗冠心病的五谷杂粮粉，其特征在于，按照重量份数计，由以下组份组成：黑芝麻14份、赤小米8份、大豆7份、燕麦20份、薏米4份、百合9份、核桃12份、血竭4份、阿胶4份、延胡索3份、郁金11份、柴胡6份、麦冬15份、黄芪4份、冰片15份、肉苁蓉9份、五味子7份、银花14份、三七7份、地龙2份、薤白6份。
4.根据权利要求1所述的治疗冠心病的五谷杂粮粉，其特征在于，按照如下方法制备：
S11，将黑芝麻、赤小米、大豆、燕麦、薏米、百合和核桃分别进行炒制，然后研磨成粉后混合，得到第一粉料；
S12，将血竭、阿胶、延胡索、郁金、柴胡、麦冬、黄芪、冰片、肉苁蓉、五味子、银花、三七、地龙、薤白粉碎，大小控制在60-100目筛，得到第二粉料；
S13，将第二粉料混合均匀，置于通透袋内，用温度为20-40℃的凉开水浸泡6-8小时；
S14，加水煎煮三次，第一次持续0.6-1.2小时，第二、三次各0.8～1.4小时，第一次加水量为第二粉料总重量的3-4倍，第二、三次加水量为第二粉料总重量的5～8倍；
S15，将煎煮后的药液加入4倍量的乙醇，乙醇为95％以上的食用酒精，充分搅拌，静置冷藏12小时，滤液回收乙醇后抽进浓缩罐，经浓缩至原体积的1/2-1/3，得浓缩液；
S16，将浓缩液液倒入离心机中高速离心，弃去不溶物得到提取液；
S17，将提取液经真空减压泵浓缩到五分之一体积后，经真空干燥机进行干燥制得第三粉料；
S18，将所述第一粉料和所述第三粉料混合后，灭菌得到所述五谷杂粮粉。
5.根据权利要求4所述的治疗冠心病的五谷杂粮粉，其特征在于，步骤S12中，所述第二粉料的大小为80-85目筛。
6.根据权利要求4所述的治疗冠心病的五谷杂粮粉，其特征在于，步骤S13中，凉开水浸泡的温度为30℃。
7.根据权利要求4所述的治疗冠心病的五谷杂粮粉，其特征在于，步骤S13中，浸泡的时间为7小时。
8.根据权利要求4所述的治疗冠心病的五谷杂粮粉，其特征在于，步骤S14中，第一次煎煮的时间为0.8-1.0小时，第一次加水量为第二粉料总重量的3.5倍。
9.根据权利要求4所述的治疗冠心病的五谷杂粮粉，其特征在于，步骤S14中，第二、三次煎煮的时间为1～1.2小时，第二、三次加水量为第二粉料总重量的7倍。
10.根据权利要求4所述的治疗冠心病的五谷杂粮粉，其特征在于，步骤S12中的冰片在粉碎之前，先将其溶于乙醇中，并用β-环糊精包合。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110067845.2A CN112806572A (zh) | 2021-01-19 | 2021-01-19 | 一种治疗冠心病的五谷杂粮粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110067845.2A CN112806572A (zh) | 2021-01-19 | 2021-01-19 | 一种治疗冠心病的五谷杂粮粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112806572A true CN112806572A (zh) | 2021-05-18 |
Family
ID=75870059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110067845.2A Pending CN112806572A (zh) | 2021-01-19 | 2021-01-19 | 一种治疗冠心病的五谷杂粮粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112806572A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105231453A (zh) * | 2015-11-18 | 2016-01-13 | 张晓彬 | 五谷杂粮心脏调理食疗保健品及其加工工艺 |
| CN106136048A (zh) * | 2016-07-25 | 2016-11-23 | 淄博上人食品有限公司 | 中老年用健康粥粉及其制备方法 |
| CN106177759A (zh) * | 2016-07-31 | 2016-12-07 | 长春中医药大学附属医院 | 一种治疗冠心病心绞痛的中药复方制剂及其制备工艺 |
| CN107998305A (zh) * | 2018-01-29 | 2018-05-08 | 安徽省纽斯康生物工程有限公司 | 一种用于治疗冠心病的中药配方 |
| CN111991539A (zh) * | 2020-09-29 | 2020-11-27 | 江西中医药大学 | 一种缓解冠心病心绞痛的中药穴位贴及其制备方法 |
-
2021
- 2021-01-19 CN CN202110067845.2A patent/CN112806572A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105231453A (zh) * | 2015-11-18 | 2016-01-13 | 张晓彬 | 五谷杂粮心脏调理食疗保健品及其加工工艺 |
| CN106136048A (zh) * | 2016-07-25 | 2016-11-23 | 淄博上人食品有限公司 | 中老年用健康粥粉及其制备方法 |
| CN106177759A (zh) * | 2016-07-31 | 2016-12-07 | 长春中医药大学附属医院 | 一种治疗冠心病心绞痛的中药复方制剂及其制备工艺 |
| CN107998305A (zh) * | 2018-01-29 | 2018-05-08 | 安徽省纽斯康生物工程有限公司 | 一种用于治疗冠心病的中药配方 |
| CN111991539A (zh) * | 2020-09-29 | 2020-11-27 | 江西中医药大学 | 一种缓解冠心病心绞痛的中药穴位贴及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 董扬洲等: "益气活血复脉汤治疗稳定型冠心病心绞痛32例临床观察", 《中医药导报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104606513B (zh) | 一种治疗心脑血管疾病的中药及其制备方法 | |
| CN102861287B (zh) | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 | |
| CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
| CN105343466A (zh) | 一种治疗冠心病的中药组合物 | |
| CN108295177A (zh) | 一种用于治疗冠心病心绞痛的中药组合物及其制备方法 | |
| CN108159213A (zh) | 一种用于治疗冠心病的中药组合物及其制备方法 | |
| CN104069446A (zh) | 一种治疗冠心病心绞痛的中药组合物 | |
| CN105311492A (zh) | 一种用于冠状动脉粥样硬化性心脏病的药物 | |
| CN112806572A (zh) | 一种治疗冠心病的五谷杂粮粉 | |
| CN115252691A (zh) | 一种用于治疗气滞血瘀型冠心病心绞痛的中药组合物 | |
| CN106822300B (zh) | 一种祛痘美颜的中药制剂 | |
| CN110882347A (zh) | 一种治疗心血管疾病的中药组合物 | |
| CN105343688A (zh) | 一种治疗心肌梗塞的药物组合物及其应用 | |
| CN104857121A (zh) | 一种治疗高血脂症的药物组合物及其应用 | |
| CN104623057A (zh) | 一种治疗糖尿病足的药物组合物及其应用 | |
| CN109771567A (zh) | 一种中草药扶正化瘀排毒化肿瘤的配方 | |
| CN113679781B (zh) | 一种治疗快速性心律失常的中药组合物及其制备方法和应用 | |
| CN116327825B (zh) | 一种用于治疗心血管疾病的中药及其制备方法 | |
| CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
| CN104324196A (zh) | 一种用于治疗白癜风的中药组合物及其汤剂、丸剂和散剂 | |
| CN104906196B (zh) | 一种用于快速室上性心律失常的复方药物及其制备方法 | |
| CN113398225A (zh) | 用于酒精性肝纤维化的中药 | |
| CN103157068B (zh) | 治疗心肌梗塞的中药组合物粉剂及其制备方法 | |
| CN118105442A (zh) | 一种治疗高热神昏、开窍醒神的药物组合物 | |
| CN104189615A (zh) | 一种治疗崩漏的中药制剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210518 |